Sort
17,288 grants matching “multiple sclerosis”
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology
$334,781Eoin P Flanagan · Mayo Clinic Rochester · R01 · FY2024 · NS
Training in Immunological Mechanisms
$334,746Michael Croft · La Jolla Institute For Immunology · T32 · FY2017 · AI
HISTAMINERGIC BASIS OF CENTRAL FATIGUE IN MULTIPLE SCLEROSIS - A NOVEL THERAPEUTIC APPROACH
$334,742University Of Miami · · FY2016 · Department of the Army
Transmission Electron Microscope
$334,703Arthur R Hand · University Of Connecticut Sch Of Med/Dnt · S10 · FY2009 · RR
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
$334,688Aron Lukacher · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · NS
The role of mouse ARL13B in cell diversification during spinal cord development
$334,688Tamara J Caspary · Emory University · R01 · FY2008 · NS
Role of QKI in oligodendroglia and myelin development
$334,688Yue Feng · Emory University · R01 · FY2008 · NS
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
$334,688Shing Yan Chiu · University Of Wisconsin-Madison · R01 · FY2017 · NS
The role of mouse ARL13B in cell diversification during spinal cord development
$334,688Tamara J Caspary · Emory University · R01 · FY2007 · NS
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
$334,688Aron Lukacher · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2015 · NS
CNS Demyelinating Autoimmunity Targeting Water Channel Complexes
$334,688Sean Joseph Pittock · Mayo Clinic Rochester · R01 · FY2014 · NS
Role of HLA Class II Genes in Demyelination
$334,688Chella S David · Mayo Clinic Rochester · R01 · FY2014 · NS
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
$334,688Aron Lukacher · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · NS
B cells alter adaptive autoimmunity to protect from ischemic injury after stroke
$334,688Ann Marie Stowe · University Of Kentucky · R01 · FY2019 · NS
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
$334,688Shing Yan Chiu · University Of Wisconsin-Madison · R01 · FY2021 · NS
The role of mouse ARL13B in cell diversification during spinal cord development
$334,688Tamara J Caspary · Emory University · R01 · FY2009 · NS
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
$334,688Shing Yan Chiu · University Of Wisconsin-Madison · R01 · FY2018 · NS
Role of QKI in oligodendroglia and myelin development
$334,688Yue Feng · Emory University · R01 · FY2009 · NS
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
$334,688Aron Lukacher · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · NS
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
$334,688Aron Lukacher · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · NS
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
$334,688Shing Yan Chiu · University Of Wisconsin-Madison · R01 · FY2020 · NS
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
$334,688Shing Yan Chiu · University Of Wisconsin-Madison · R01 · FY2019 · NS
Manual Control of the Upper Esophageal Sphincter
$334,679Peter Belafsky · University Of California At Davis · R01 · FY2012 · DK
Mechanisms of immune homeostasis and regulation of intraocular inflammation
$334,663Charles E Egwuagu · National Eye Institute · ZIA · FY2018 · EY
Fast Functional MRI with Sparse Sampling and Model-Based Reconstruction
$334,663Douglas C Noll · University Of Michigan At Ann Arbor · R01 · FY2020 · EB